Anne B. Johnson, MD

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Madhavarao CN, Arun P, Moffett JR, et al. (2005) Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 5221-6
van der Knaap MS, Salomons GS, Li R, et al. (2005) Unusual variants of Alexander's disease. Annals of Neurology. 57: 327-38
Li R, Johnson AB, Salomons G, et al. (2005) Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Annals of Neurology. 57: 310-26
Johnson AB. (2004) Alexander disease: a leukodystrophy caused by a mutation in GFAP. Neurochemical Research. 29: 961-4
Johnson AB, Brenner M. (2003) Alexander's disease: clinical, pathologic, and genetic features. Journal of Child Neurology. 18: 625-32
Cash AD, Aliev G, Siedlak SL, et al. (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. The American Journal of Pathology. 162: 1623-7
Johnson AB. (2002) Alexander disease: a review and the gene. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 20: 391-4
Messing A, Goldman JE, Johnson AB, et al. (2001) Alexander disease: new insights from genetics. Journal of Neuropathology and Experimental Neurology. 60: 563-73
Brenner M, Johnson AB, Boespflug-Tanguy O, et al. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genetics. 27: 117-20
Hirai K, Aliev G, Nunomura A, et al. (2001) Mitochondrial Abnormalities in Alzheimer's Disease The Journal of Neuroscience. 21: 3017-3023